263 related articles for article (PubMed ID: 17305260)
1. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
Shaw PH; Adams R; Jordan C; Crosby TD
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
[TBL] [Abstract][Full Text] [Related]
2. Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study.
Reinert CP; Sekler J; la Fougère C; Pfannenberg C; Gatidis S
Eur Radiol; 2020 Mar; 30(3):1325-1333. PubMed ID: 31728688
[TBL] [Abstract][Full Text] [Related]
3. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
4. [Carcinoma of unknown primary site. Apropos of 100 patients treated at the Montpellier regional center of cancer prevention].
Culine S; Gazagne L; Ychou M; Romieu G; Fabbro M; Cupissol D; Dubois JB
Rev Med Interne; 1998 Oct; 19(10):713-9. PubMed ID: 9827443
[TBL] [Abstract][Full Text] [Related]
5. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.
Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K
BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713
[TBL] [Abstract][Full Text] [Related]
6. Liver metastases from adenocarcinomas of unknown primary site: management and prognosis in 68 consecutive patients.
Algin E; Ozet A; Gumusay O; Yilmaz G; Buyukberber S; Coskun U; Baykara M; Cetin B; Yıldız R; Benekli M
Wien Klin Wochenschr; 2016 Jan; 128(1-2):42-7. PubMed ID: 26373751
[TBL] [Abstract][Full Text] [Related]
7. Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature.
Lazaridis G; Pentheroudakis G; Fountzilas G; Pavlidis N
Cancer Treat Rev; 2008 Dec; 34(8):693-700. PubMed ID: 18584969
[TBL] [Abstract][Full Text] [Related]
8. Hepatic metastases from an unknown primary neoplasm (UPN): survival, prognostic indicators and value of extensive investigations.
Hogan BA; Thornton FJ; Brannigan M; Browne TJ; Pender S; O'Kelly P; Lyon SM; Lee MJ
Clin Radiol; 2002 Dec; 57(12):1073-7. PubMed ID: 12475531
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.
Li X; Shao Y; Sheng L; Zhu J; Wang Z; Guo K; Sun L
Cancer Med; 2021 Feb; 10(3):974-988. PubMed ID: 33405390
[TBL] [Abstract][Full Text] [Related]
10. Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.
Raghav K; Mhadgut H; McQuade JL; Lei X; Ross A; Matamoros A; Wang H; Overman MJ; Varadhachary GR
PLoS One; 2016; 11(5):e0154985. PubMed ID: 27171493
[TBL] [Abstract][Full Text] [Related]
11. Survival outcomes following craniotomy for intracranial metastases from an unknown primary.
Gough M; Nielsen M; Coulter IC; Holliman D
Int J Clin Oncol; 2020 Aug; 25(8):1475-1482. PubMed ID: 32358736
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.
Kodaira M; Yonemori K; Shimoi T; Yoshida A; Yoshida M; Kitano A; Shimomura A; Yunokawa M; Shimizu C; Takiguchi Y; Fujiwara Y; Tamura K
BMC Cancer; 2018 Feb; 18(1):176. PubMed ID: 29433539
[TBL] [Abstract][Full Text] [Related]
14. New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis.
Trivanović D; Petkovic M; Stimac D
Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):43-8. PubMed ID: 18976894
[TBL] [Abstract][Full Text] [Related]
15. Survival in cancer of unknown primary site: population-based analysis by site and histology.
Hemminki K; Bevier M; Hemminki A; Sundquist J
Ann Oncol; 2012 Jul; 23(7):1854-63. PubMed ID: 22115926
[TBL] [Abstract][Full Text] [Related]
16. Gamma Knife Radiosurgery for Metastatic Brain Tumors from Cancer of Unknown Primary.
Matsunaga S; Shuto T; Kobayashi N
World Neurosurg; 2019 Feb; 122():e1465-e1471. PubMed ID: 30468925
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.
Leone JP; Leone J; Zwenger AO; Iturbe J; Leone BA; Vallejo CT
Eur J Cancer; 2017 Mar; 74():17-25. PubMed ID: 28335884
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of unknown primary: retrospective study of 437 patients treated at Salah Azaiez Institute.
Fehri R; Rifi H; Alboueiri A; Malouche D; Ayadi M; Rais H; Mezlini A
Tunis Med; 2013 Mar; 91(3):205-8. PubMed ID: 23588636
[TBL] [Abstract][Full Text] [Related]
19. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
[TBL] [Abstract][Full Text] [Related]
20. Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients.
Deng K; Yang C; Tan Q; Song W; Lu M; Zhao W; Lou G; Li Z; Li K; Hou Y
Gynecol Oncol; 2018 Sep; 150(3):460-465. PubMed ID: 30001833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
